Persistence Market Research published a report on thefreeze & thaw systems market, which considers the global industry analysis 2014 – 2018 and forecast 2019-2029, and projects that the freeze & thaw systems market is expected to reach ~US$ 270 Mnby the end of 2019 in terms of value, and is forecasted to reach ~US$ 550 Bnby the end of 2029.
Increasing Demand for Disposable Systems Anticipated to Drive the Growth of the Freeze & Thaw Market
The demand for disposable freeze & thaw systems is increasing as these offer many benefits. For instance, disposable freeze & thaw systems developed by Sartorius Stedim Biotech could be assessed as products with potential to replace large container-based freeze & thaw stainless steel tanks. These freeze & thaw systems have capacity equivalent to a 100L bag-in-box vessel, and are set with equipment needed for freeze & thaw, transportation, and storage of these containers.
Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/15760
Company Profiles:
- BioLifeSolutions, Inc.
- CARON Products & Services, Inc.
- Farrar Scientific
- GE Healthcare Life Sciences
- HOF Sonderanlagenbau GmbH
- Meissner Filtration Products, Inc.
- Precision Cryosystems
- Sartorius AG
- Single Use Support GmbH
- Thermo Fisher Scientific, Inc.
- W. L. Gore & Associates, Inc.
- ZETA Holding GmbH
Disposable freeze & thaw system bags get filled with raw materials of larger capacity in comparison to ones that are made up of stainless steel. These also get frozen immediately due to the provision of heat exchange plates. This arrangement provides effective and efficient heat transfer as well as protection of the bag. One can also monitor the progress of freezing in disposable freeze & thaw systems through a temperature sensor, which is located at the centerline of the container.
With so many advantages to offer, it is likely that the market of freeze & thaw systems will be driven by the increased demand for disposable freeze & thaw products in product manufacturing industries.
Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/15760
Increasing Demand for Freeze & Thaw Systems in the Biopharmaceutical Industry
The freeze & thaw systems market is also driven by the presence of large biopharmaceutical companies that install these systems in their manufacturing units. With growing regional expansion of biopharmaceutical industries, the market of freeze & thaw systems is also likely grow significantly in the forecast period due to the increasing demand in product manufacturing. In these industries, freeze & thaw systems are supplied with containers for process development and aseptic transfers from lab to industrial scales.
Freeze & thaw systems are equipped with three key components: cooling and heating unit, a container, and a thawing device. The container is used for quick freezing, thawing, and transporting biopharmaceutical products. The thawing device is used for seamless execution of the batch process. Besides, another advantage of using freeze & thaw systems is that these can also be used in research and development where the process operation takes place with minimal amount of product.
Growth of the Healthcare Industry in Emerging Nations to Fuel the Growth of the Freeze and Thaw Market
According to the World Bank, in recent years, various emerging economies of East and South Asia have witnessed increase in the ease of doing business. As a result, these countries are witnessing spur in FDI (Foreign direct investment).
Developing regions such as China, India, Malaysia, and Indonesia have outstripped economic growth compared to developed economies. This, in turn, is expected to drive the growth investment across various domains including healthcare sector in these countries.
Access Full Report @https://www.persistencemarketresearch.com/checkout/15760
According to a World Bank report, China’s invested almost6%of its GDP in 2016 for improving its healthcare sector and this expenditure is expected to double by 2020 due to the country’s aggressive healthcare development plan.
Changing demographics in emerging nations is expected to boost growth opportunities for medical devices and healthcare companies including those that manufacture freeze & thaw systems. Moreover, due to the growing healthcare infrastructure in these regions, both regions are lucrative markets for freeze & thaw system manufacturers to invest and could fetch high dividends.
Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape
Molecular Diagnostics Market –
Molecular Diagnostics MarketSegmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.
Next-Generation Sequencing Market –
Next Generation Sequencing MarketSegmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.
Ophthalmology devises Market –
Ophthalmology devises MarketSegmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.
Intravenous Iron Drugs Market –
Intravenous (IV) Iron Drugs MarketSegmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.
Syndromes Progressive Ataxia Weakness Disorders Market –
Treatments forSyndromes of Progressive Ataxia and Weakness Disorders MarketSegmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id-sales@persistencemarketresearch.com
Website:https://www.persistencemarketresearch.com
Contact Information:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
Contact Information:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com